Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - MICROFLUIDICS INTERNATIONAL CORP | aq4pr.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of
Report: February 23, 2010 (Date of earliest event reported)
MICROFLUIDICS INTERNATIONAL
CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware 0-11625
04-2793022
(State
or other jurisdiction of
incorporation) (Commission File Number) (IRS
Employer Identification No.)
30
Ossipee Road
Newton,
MA 02464
(Address
of principal executive offices)
Telephone:
(617) 969-5452
(Registrant's
telephone number, including area code)
|
q
|
Written communications pursuant
to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
q
|
Soliciting material pursuant
to Rule 14a-12 under
the Exchange Act (17 CFR
240.14a-12)
|
|
q
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR
240.14d-2(b))
|
|
q
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02 Results
of Operations and Financial Condition.
On
February 23, 2010, Microfluidics International Corporation issued a press
release entitled “Microfluidics International Corporation Announces Fourth
Quarter and Year-End 2009 Financial Results.” A copy of the press
release is attached as Exhibit 99.1 to this report and is incorporated by
reference into this Item 2.02.
NON-GAAP
FINANCIAL MEASURES: The attached press release addresses our financial results
for the fourth quarter and year end December 31, 2009, and contains disclosure
of our non-GAAP EBITDA (Earnings Before Interest, Taxes, Depreciation and
Amortization), and non-GAAP adjusted EBITDA which are not measures of financial
performance calculated in accordance with generally accepted accounting
principles (GAAP) in the United States. The press release contains disclosure
regarding why we believe the presentation of these non-GAAP measures provides
useful information to investors in analyzing our underlying business and
operating performance. It also contains a tabular reconciliation of GAAP to
non-GAAP financial information that is discussed in the release.
The
information being provided in this report, including Exhibit 99.1, shall not be
deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act
of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that
section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as expressly
set forth by specific reference in such a filing.
Item
9.01 Financial
Statements and Exhibits.
(d) The
following exhibit is hereby filed as part of this Current Report on Form
8-K:
Number Exhibit
|
99.1
|
Press
Release titled “Microfluidics International Corporation Announces Fourth
Quarter and Year-End 2009 Financial
Results”
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated:
February 23,
2010 MICROFLUIDICS
INTERNATIONAL CORPORATION
By: /s/ Peter F. Byczko
-----------------------------------
Name: Peter F.
Byczko
|
|
Title: Vice
President of Finance & Chief Accounting
Officer
|
EXHIBIT
INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
Release titled “Microfluidics International Corporation Announces Fourth
Quarter and Year-End 2009 Financial
Results”
|